US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Cleo Diagnostics Ltd (COV) 銘柄情報

Cleo Diagnostics Ltd (COV)

0.51

0.00

(0.00%)

終了 6月11日 3:00PM

Cleo Diagnostics Ltd (COV) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.51

( - )

買値

0.495

売値

0.525

出来高

62,607

0.49 日の範囲 0.52

0.335 52 週間の範囲 0.90

時価総額

前日終値

0.51

始値

0.51

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 169,467

発行済株式数

136,862,085

配当利回り

PER

-16.42

1 株当たり利益 (EPS)

-0.03

歳入

2.56M

純利益

-4.03M

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determi... Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cleodx.com

本社

Melbourne, Australia

設立

2026

Cleo Diagnostics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker COV. The last closing price for Cleo Diagnostics was AUD0.51. Over the last year, Cleo Diagnostics shares have traded in a share price range of AUD 0.335 to AUD 0.90.

Cleo Diagnostics currently has 136,862,085 shares in issue. The market capitalisation of Cleo Diagnostics is AUD69.80 million. Cleo Diagnostics has a price to earnings ratio (PE ratio) of -16.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.03	-5.55555555556	0.54	0.55	0.49	114438	0.52464562	DE
4	-0.165	-24.4444444444	0.675	0.7	0.49	153948	0.60328313	DE
12	0.015	3.0303030303	0.495	0.75	0.465	168045	0.59193691	DE
26	-0.13	-20.3125	0.64	0.9	0.4575	245434	0.62950761	DE
52	0.155	43.661971831	0.355	0.9	0.335	210059	0.55516629	DE
156	0.28	121.739130435	0.23	0.9	0.14	168124	0.43279063	DE
260	0.28	121.739130435	0.23	0.9	0.14	168124	0.43279063	DE

COV - Frequently Asked Questions (FAQ)

What is the current Cleo Diagnostics Ltd share price?

The current share price of Cleo Diagnostics Ltd is AUD 0.51

How many Cleo Diagnostics Ltd shares are in issue?

Cleo Diagnostics Ltd has 136,862,085 shares in issue

What is the market cap of Cleo Diagnostics Ltd?

The market capitalisation of Cleo Diagnostics Ltd is AUD 69.8M

What is the 1 year trading range for Cleo Diagnostics Ltd share price?

Cleo Diagnostics Ltd has traded in the range of AUD 0.335 to AUD 0.90 during the past year

What is the PE ratio of Cleo Diagnostics Ltd?

The price to earnings ratio of Cleo Diagnostics Ltd is -16.42

What is the cash to sales ratio of Cleo Diagnostics Ltd?

The cash to sales ratio of Cleo Diagnostics Ltd is 27.51

What is the registered address of Cleo Diagnostics Ltd?

The registered address for Cleo Diagnostics Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Cleo Diagnostics Ltd website address?

The website address for Cleo Diagnostics Ltd is www.cleodx.com

haha11

$SPY...15.....NOW STILL UNDER MA50 Monitor %B....

S..725.48...

https://stockcharts.com/sc3/ui/?s=SPY&id=p54653479432&a=234724271

ysung

So when do they come back from vacation ???

jrf30

very complete report. I like that. Don]t think the volatility would put this at 0.31, but all the rest looks good, and there is a lot of information on that page. Thank you.

JCESOSA

JCESOSA 4分前

Agreed. Something bigger must be on the way

EpicSage

EpicSage 4分前

$OTLC ’s PDAOAI™ indexes 28M PubMed abstracts on Qdrant & introduces manifold folding to fix the infinity problem in biomedical retrieval — a milestone for AI-driven drug discovery.

Full story: https://wix.to/siP3GXN

#Oncotelic #PDAOAI #Biotech #AI

sjoseph

sjoseph 4分前

He doesn’t have 400 million after 1/10 Reverse split. Around 41 million and that will never hit the market now. GL

88TH MAN

88TH MAN 5分前

USMJ: Bullish!!!

jay14

Perhaps noise makers, drenching up old news from 1993 or even 2003 should contact Susan Bala directly....
Ask her to join TMMI legal team with all this information....
Speculation of what's coming up with this new court case, with a new judge is just that speculation, and nothing more!

Truenorth2016

Truenorth2016 5分前

I dont think the tweet is saying they will never provide the detailed amounts of the contract, they are just saying they cant release the info now....they will do like they did the other contract and eventually provide the info in a Tweet

iHub News

iHub News 6分前

K-Tech Solutions Advances 5 MW Computing Infrastructure Project in Canada With Construction and Testing Underway (KMRK)June 11, 2026 10:39 AM
IH Market News

FrostyIsland3

FrostyIsland3 6分前

LC2020: There is only question investors need NWBO to answer now. Has NWBO received a CHM Letter regarding the DCVax-L MAA?

If the answer is yes, NWBO is going through an appeal of the CHM Letter now and the MHRA will probably reject the DCVax-L MAA.

If the answer is

iHub News

iHub News 6分前

Laser Photonics Completes Laser Shield Anti-Drone Prototype, Advancing LSAD Demonstration Phase (LASE)June 11, 2026 10:35 AM
IH Market News

iHub News

iHub News 6分前

Purple Biotech Presents New IM1240 Preclinical Data Showing Anti-Tumor Activity and Broad Therapeutic Window (PPBT)June 11, 2026 10:38 AM
IH Market News

nowwhat2

nowwhat2 6分前

Absolutely !.....Makes sense !

Meanwhile ;

https://investorshub.advfn.com/uimage/uploads/2026/6/11/hzpvfgutsi_drunk_today_yet.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/11/d[fzkgutsi_girl_swag.jpg

https://investorshub.advfn.co

LOB

Saw Large Bid at .0097 for 3 Mins, then it disappeared without being Hit .. ?? .01+ today or tomorrow??

iHub News

iHub News 6分前

Enliven Therapeutics Reports Positive Phase 1 CML Data and FDA Alignment for Phase 3 Trial (ELVN)June 11, 2026 10:36 AM
IH Market News

iHub News

iHub News 6分前

Super Micro Prices $7 Billion AI Server Financing Package to Support $39 Billion Order Backlog (SMCI)June 11, 2026 10:37 AM
IH Market News

Karma84

Karma84 6分前

Well the idiot has only admitted in 18 posts here to buying with insider and cohen telling him when to buy. So do the math. Cohen couldn’t and he’s facing up to life in prison now.

https://x.com/opinioncasino/status/2064356081531269126?s=46&t=GJF4mYq9oxQgaoD9fp1cvw

tisdal

I think today is what we'll see from here on out. Rising on low volume. Not many sellers out there.

IMHO, the MMs are looking for inventory. They are going to drop it to kick off sell orders. They will run it up to kick off sell orders.

In the end, I think the dem

joe botts

joe botts 7分前

jrf30

I put in for 1,000 shares of the IPO. Don't know if I'll get ANY or not. Doubt I get more than 100 IF they give me any. Will find out after the market close today. KNock on wood! I doubt I buy on the open market tomorrow. Just hoping to get some at the $135 level. :-)

zdog1954

zdog1954 7分前

Thanks for posting, now that the dam has been breached, maybe the licenses from all these others will start streaming in.

vlispxpert

vlispxpert 8分前

TM does have history of upper $160's bounce level...so it may flush $170 breakdown, but loading here is almost fish in barrel imo

MrBean-4

MrBean-4 8分前

rumor at SWA is that the company has long term plans to acquire a couple of 787's to fly out of Austin and one other airport for European destinations

BBANBOB

BBANBOB 9分前

Augster
I would suggest that since ISOPET is already in use their goal was only to have a RADIO ACTIVE PRODUCTION license so they could then inhouse manufacture and legally handle/possess the RADIO ACTIVE MATERIAL

Cleo Diagnostics

Jpmorgan Chase Financial...

New Oriental Education &...

Pure Harvest Corporate (ID)

Bmo Managed Equity Growt...

DAXplus Maximum Dividend...

INTER CONSTRUTORA ON

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。